164 related articles for article (PubMed ID: 19461514)
1. Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings.
Tacconelli E
Curr Opin Infect Dis; 2009 Aug; 22(4):352-8. PubMed ID: 19461514
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Antibiotic Stewardship Programs in Combating Quinolone Resistance: A Systematic Review and Recommendations for More Efficient Interventions.
Pitiriga V; Vrioni G; Saroglou G; Tsakris A
Adv Ther; 2017 Apr; 34(4):854-865. PubMed ID: 28303388
[TBL] [Abstract][Full Text] [Related]
3. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
[TBL] [Abstract][Full Text] [Related]
4. Selective digestive tract decontamination--will it prevent infection with multidrug-resistant gram-negative pathogens but still be applicable in institutions where methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci are endemic?
Bonten MJ
Clin Infect Dis; 2006 Sep; 43 Suppl 2():S70-4. PubMed ID: 16894518
[TBL] [Abstract][Full Text] [Related]
5. [Healthcare associated infections (HAI), antibiotic use and prevalence of multidrug-resistant bacteria (MDRO) in residents of long-term care facilities: the Frankfurt HALT plus MDRO project 2012].
Heudorf U; Gustav C; Mischler D; Schulze J
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Apr; 57(4):414-22. PubMed ID: 24658671
[TBL] [Abstract][Full Text] [Related]
6. [Development of antimicrobial resistance in Germany : What is the current situation?].
Maechler F; Geffers C; Schwab F; Peña Diaz LA; Behnke M; Gastmeier P
Med Klin Intensivmed Notfmed; 2017 Apr; 112(3):186-191. PubMed ID: 28378152
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Reducing Antibiotics on the Transmission of Multidrug-Resistant Organisms.
Barnes SL; Rock C; Harris AD; Cosgrove SE; Morgan DJ; Thom KA
Infect Control Hosp Epidemiol; 2017 Jun; 38(6):663-669. PubMed ID: 28270258
[TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study.
Raymond J; Nordmann P; Doit C; Vu Thien H; Guibert M; Ferroni A; Aujard Y
Pediatrics; 2007 Apr; 119(4):e798-803. PubMed ID: 17403822
[TBL] [Abstract][Full Text] [Related]
9. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.
Hidron AI; Edwards JR; Patel J; Horan TC; Sievert DM; Pollock DA; Fridkin SK; ;
Infect Control Hosp Epidemiol; 2008 Nov; 29(11):996-1011. PubMed ID: 18947320
[TBL] [Abstract][Full Text] [Related]
10. Healthcare epidemiology: active surveillance cultures and contact precautions for control of multidrug-resistant organisms: ethical considerations.
Santos RP; Mayo TW; Siegel JD
Clin Infect Dis; 2008 Jul; 47(1):110-6. PubMed ID: 18491966
[TBL] [Abstract][Full Text] [Related]
11. [Emergence pathogens infections in ENT Department of Children's hospital in 2005-2008].
Zielnik-Jurkiewicz B; Rakowska-Szkudlarek M
Otolaryngol Pol; 2009; 63(6):513-9. PubMed ID: 20198987
[TBL] [Abstract][Full Text] [Related]
12. [Multidrug-resistant bacteria in Germany. The impact of sources outside healthcare facilities].
Idelevich EA; Lanckohr C; Horn D; Wieler LH; Becker K; Köck R
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Jan; 59(1):113-23. PubMed ID: 26446586
[TBL] [Abstract][Full Text] [Related]
13. Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review.
de Bruin MA; Riley LW
BMC Infect Dis; 2007 Apr; 7():24. PubMed ID: 17425800
[TBL] [Abstract][Full Text] [Related]
14. [Surveillance of healthcare associated infections, bacterial resistance and antibiotic consumption in high-complexity hospitals in Colombia, 2011].
Villalobos AP; Barrero LI; Rivera SM; Ovalle MV; Valera D
Biomedica; 2014 Apr; 34 Suppl 1():67-80. PubMed ID: 24968038
[TBL] [Abstract][Full Text] [Related]
15. Management of serious nosocomial bacterial infections: do current therapeutic options meet the need?
Lode H
Clin Microbiol Infect; 2005 Oct; 11(10):778-87. PubMed ID: 16153251
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of health care associated infections and bacterial resistance : guidance for good practice].
Foguena AK; Cometta A; Senn L
Rev Med Suisse; 2016 Nov; 12(540):2026-2032. PubMed ID: 28696611
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care--prevalence and risk factors.
Gruber I; Heudorf U; Werner G; Pfeifer Y; Imirzalioglu C; Ackermann H; Brandt C; Besier S; Wichelhaus TA
Int J Med Microbiol; 2013 Dec; 303(8):405-9. PubMed ID: 23770266
[TBL] [Abstract][Full Text] [Related]
18. Advances in antibacterial therapy against emerging bacterial pathogens.
Pournaras S; Iosifidis E; Roilides E
Semin Hematol; 2009 Jul; 46(3):198-211. PubMed ID: 19549574
[TBL] [Abstract][Full Text] [Related]
19. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
Napolitano LM
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
[TBL] [Abstract][Full Text] [Related]
20. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
